This is reminiscent of a recent study describing that a CD73-targeted therapy increased CD8+ T-cell infiltration in a murine mammary carcinoma cell line TSA tumor hind-leg model only in combination with additional single high-dose tumor irradiation (20 Gy) (80). The gene discussed is CD8A; the disease is breast carcinoma.